NCT05071534 is a clinical trial in Robson Classification System, sponsored by Sohag University.

Who is sponsoring NCT05071534?

NCT05071534 is sponsored by Sohag University.

What condition does NCT05071534 study?

NCT05071534 studies Robson Classification System.

Is NCT05071534 still recruiting?

NCT05071534 is currently completed. Last updated 31 May 2022.

Last reviewed 2022-05-31 · How we verify

NCT05071534

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of the Robson Classification of Cesearn Section in Sohag University Hospital

Completed Last updated 31 May 2022

What this trial tests

trial in Robson Classification System in 1,234 participants. Completed in 1 May 2022.

Timeline

1 November 2021

Primary endpoint
1 May 2022

1 May 2022

Quick facts

Lead sponsor	Sohag University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,234
Start date	1 November 2021
Primary completion	1 May 2022
Estimated completion	1 May 2022
Sites	1 location across Egypt

Conditions studied

Robson Classification System — all drugs for Robson Classification System →

Sponsor

Sohag University

Who can join

Adults 15 to 45, female only, with Robson Classification System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim Of The Work find out the frequency and indications for CS in sohag university hospitals and to analyze them according to Robson' ten group classification. This would be helping in adopting suitable measures to reduce the CS rate and identifying various challenges in our setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05071534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 31 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05071534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing